Femoston-Conti

Femoston-Conti is a hormone preparation that relieves menopausal symptoms. This type of treatment is known as hormone replacement therapy (HRT). Femoston-Conti contains two active ingredients, estradiol and dydrogesterone, which are forms of the main female sex hormones oestrogen and progestogen. These hormones replace the falling levels of hormones in the body and reduce the symptoms of menopause. Femoston-Conti is a prescription-only medicine.

Femoston-Conti is a hormone preparation that relieves menopausal symptoms. This type of treatment is known as hormone replacement therapy (HRT). Femoston-Conti contains two active ingredients, estradiol and dydrogesterone, which are forms of the main female sex hormones oestrogen and progestogen. These hormones replace the falling levels of hormones in the body and reduce the symptoms of menopause. Femoston-Conti is a prescription-only medicine.

Femoston-Conti is used to treat a wide range of menopausal symptoms, including:

• Hot flushes;
• Night sweats;
• Dryness of mucous membranes (eyes, vagina and/or mouth);
• Irritability, mood swings;
• Insomnia;
• Depression;
• Loss of libido (sex drive);
• Osteoporosis (decrease in bone mass and density).

The estradiol in Femoston-Conti relieves menopausal symptoms. Dydrogesterone is added to protect the uterus from side effects such as endometrial cancer. Each Femoston-Conti tablet contains a low dose of both hormones. This type of HRT does not produce a monthly withdrawal bleed, and so is more suitable for women whose periods have already stopped or women who have not had a period for at least 12 months.

Femoston-Conti tablets should be swallowed whole with some water without chewing. They can be taken with or without food. Femoston-Conti is available in blister packs containing 28 tablets. The tablets should be taken back-to-back without a tablet-free interval. Femoston-Conti tablets do not cause a monthly withdrawal bleed, but you may experience spotting or breakthrough bleeding during the first few months of treatment. For more information on how to use Femoston-Conti tablets, see the package leaflet.

Unless otherwise advised by the doctor, the usual dose in adult women is one Femoston-Conti tablet once a day. Do not exceed the recommended dose and read the package leaflet carefully before use.

Femoston-Conti tablets may cause side effects, including:

• Headache;
• Gastrointestinal symptoms such as nausea or stomach ache;
• Breakthrough bleeding;
• Vaginal discharge;
• Breast tenderness or soreness;
• Mood swings.

Consult a doctor if the side effects are persistent. Make sure that you read the package leaflet before you start using this medicine for important information about possible serious side effects that are associated with HRT use.

Femoston-Conti tablets are not suitable for everyone. Do not use this HRT preparation if you:

• Are allergic to estradiol, dydrogesterone or any other ingredient in this medicine;
• Have a known or past history of thrombosis or liver disease;
• Have active breast cancer or a history of breast cancer or other hormone-related cancer;
• Have a blood disease or kidney disorder, vaginal bleeding of unknown cause or an overgrowth of the lining of the womb (endometrial hyperplasia).

Consult a doctor on the use of Femoston-Conti tablets if you have a health problem that is not listed above, and tell them which other medicines you are taking, to avoid potential interaction and make sure that the combination with Femoston-Conti is safe.

HRT is a treatment used to relieve the symptoms of menopause. Women who are still fertile should not use Femoston-Conti tablets if pregnant or breastfeeding, unless the doctor advises otherwise.

Warning: Femoston-Conti tablets are not a contraceptive pill and do not protect against pregnancy.

Femoston-Conti tablets do not interact with alcohol or affect your ability to drive safely.